December 2013

Bortezomib induced reversible left ventricular systolic dysfunction: A case report and review of literature.

Introduction Bortezomib is a reversible proteasome inhibitor, currently approved by US FDA for use...
Aggression and Homicidal Thoughts in a Patient with Primary Hyperparathyroidism: A Case Report.

Introduction: We report a case of worsening psychiatric symptoms in a patient who was...
Biologics in Dermatology: A Brief Review

INTRODUCTION The US Food and Drug Administration (USFDA) considers the following as biologics: any...
Daycase Anterior Cruciate Ligament Reconstruction: Success, Pitfalls and Patient Pain Scores

Introduction Anterior Cruciate Ligament (ACL) reconstructions are increasingly being undertaken...